Sale of Birken AG to Amryt Pharmaceuticals

BDO.LiveSite.Deals.IndustryLife Sciences
BDO.LiveSite.Deals.ClientNameBirken AG

BDO provided Corporate Finance advice to Birken AG on their sale to Amryt Pharmaceuticals.

Birken is a revenue generating pharmaceutical development and manufacturing company based in Germany. They have developed a recently approved drug for partial thickness wounds and promising potential orphan drug candidate for epidermolysis bullosa (EB").

The acquisition of Birken AG is an important step for Amryt Pharmaceuticals to build a speciality pharmaceutical company focused on best in class treatments for Orphan Diseases.